| Abstrakt: |
Preferably, the antiviral lectins may be GRFT and CV-N. "The polymer-lipid microemulsion delivery system may be a liquid and may be nebulised for delivery by inhalation, including for pulmonary delivery. "The process may optionally further comprise a final step of drying the stabilised polymer-lipid microemulsion to produce a free flowing polymer-lipid microemulsion powder either by freeze drying or by spray drying. The process according to any one of claims 19 to 23, wherein the process optionally further comprises a final step of drying the stabilised polymer-lipid microemulsion to produce a free flowing polymer-lipid microemulsion powder either by freeze drying or by spray drying. " "The process may further comprise an additional step of drying the stabilised polymer-lipid microemulsion to produce a free flowing polymer-lipid nanocomplex powder either by freeze drying or by spray drying. [Extracted from the article] |
